These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 32709718)

  • 61. A novel mutation in pmrB mediates colistin resistance during therapy of Acinetobacter baumannii.
    Dahdouh E; Gómez-Gil R; Sanz S; González-Zorn B; Daoud Z; Mingorance J; Suárez M
    Int J Antimicrob Agents; 2017 Jun; 49(6):727-733. PubMed ID: 28438568
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Enhanced antibacterial effect of the novel T4-like bacteriophage KARL-1 in combination with antibiotics against multi-drug resistant Acinetobacter baumannii.
    Jansen M; Wahida A; Latz S; Krüttgen A; Häfner H; Buhl EM; Ritter K; Horz HP
    Sci Rep; 2018 Sep; 8(1):14140. PubMed ID: 30237558
    [TBL] [Abstract][Full Text] [Related]  

  • 63. New pharmacokinetic/pharmacodynamic studies of systemically administered colistin against Pseudomonas aeruginosa and Acinetobacter baumannii in mouse thigh and lung infection models: smaller response in lung infection.
    Cheah SE; Wang J; Nguyen VT; Turnidge JD; Li J; Nation RL
    J Antimicrob Chemother; 2015 Dec; 70(12):3291-7. PubMed ID: 26318190
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options.
    Kempf M; Rolain JM
    Int J Antimicrob Agents; 2012 Feb; 39(2):105-14. PubMed ID: 22113193
    [TBL] [Abstract][Full Text] [Related]  

  • 65. In vivo antibacterial activity of Zataria multiflora Boiss extract and its components, carvacrol, and thymol, against colistin-resistant Acinetobacter baumannii in a pneumonic BALB/c mouse model.
    Hassannejad N; Bahador A; Rudbari NH; Modarressi MH; Parivar K
    J Cell Biochem; 2019 Nov; 120(11):18640-18649. PubMed ID: 31338900
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Antimicrobial and biofilm inhibiting potential of an amide derivative [N-(2', 4'-dinitrophenyl)-3β-hydroxyurs-12-en-28-carbonamide] of ursolic acid by modulating membrane potential and quorum sensing against colistin resistant Acinetobacter baumannii.
    Usmani Y; Ahmed A; Faizi S; Versiani MA; Shamshad S; Khan S; Simjee SU
    Microb Pathog; 2021 Aug; 157():104997. PubMed ID: 34048890
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evaluation of resazurin-based rapid test to detect colistin resistance in Acinetobacter baumannii isolates.
    Germ J; Poirel L; Kisek TC; Spik VC; Seme K; Premru MM; Zupanc TL; Nordmann P; Pirs M
    Eur J Clin Microbiol Infect Dis; 2019 Nov; 38(11):2159-2162. PubMed ID: 31372908
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Assessment of early combination effects of colistin and meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii in dynamic time-kill experiments.
    Tängdén T; Karvanen M; Friberg LE; Odenholt I; Cars O
    Infect Dis (Lond); 2017 Jul; 49(7):521-527. PubMed ID: 28264618
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Emergence of High-Level Colistin Resistance in an Acinetobacter baumannii Clinical Isolate Mediated by Inactivation of the Global Regulator H-NS.
    Deveson Lucas D; Crane B; Wright A; Han ML; Moffatt J; Bulach D; Gladman SL; Powell D; Aranda J; Seemann T; Machado D; Pacheco T; Marques T; Viveiros M; Nation R; Li J; Harper M; Boyce JD
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712662
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Novel Phage Lysin Abp013 against
    Chu JJK; Poh WH; Hasnuddin NTB; Hew EY; Dam LC; Sahili AE; Rice SA; Goh BC
    Antibiotics (Basel); 2022 Jan; 11(2):. PubMed ID: 35203772
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Rapid screening of colistin-resistant Escherichia coli, Acinetobacter baumannii and Pseudomonas aeruginosa by the use of Raman spectroscopy and hierarchical cluster analysis.
    Lin Z; Zhao X; Huang J; Liu W; Zheng Y; Yang X; Zhang Y; Lamy de la Chapelle M; Fu W
    Analyst; 2019 Apr; 144(8):2803-2810. PubMed ID: 30882113
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii.
    García-Quintanilla M; Carretero-Ledesma M; Moreno-Martínez P; Martín-Peña R; Pachón J; McConnell MJ
    Int J Antimicrob Agents; 2015 Dec; 46(6):696-702. PubMed ID: 26391380
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Characterization of a Novel Phage ΦAb1656-2 and Its Endolysin with Higher Antimicrobial Activity against Multidrug-Resistant
    Kim K; Islam MM; Kim D; Yun SH; Kim J; Lee JC; Shin M
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578429
    [No Abstract]   [Full Text] [Related]  

  • 74. In vitro synergism of colistin in combination with N-acetylcysteine against Acinetobacter baumannii grown in planktonic phase and in biofilms.
    Pollini S; Boncompagni S; Di Maggio T; Di Pilato V; Spanu T; Fiori B; Blasi F; Aliberti S; Sergio F; Rossolini GM; Pallecchi L
    J Antimicrob Chemother; 2018 Sep; 73(9):2388-2395. PubMed ID: 29846610
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme.
    Yau W; Owen RJ; Poudyal A; Bell JM; Turnidge JD; Yu HH; Nation RL; Li J
    J Infect; 2009 Feb; 58(2):138-44. PubMed ID: 19058855
    [TBL] [Abstract][Full Text] [Related]  

  • 76. In vivo activity of vancomycin combined with colistin against multidrug-resistant strains of Acinetobacter baumannii in a Galleria mellonella model.
    Yang H; Lv N; Hu L; Liu Y; Cheng J; Ye Y; Li J
    Infect Dis (Lond); 2016; 48(3):189-94. PubMed ID: 26503239
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Discrepancies in susceptibility testing to colistin in Acinetobacter baumannii: The influence of slow growth and heteroresistance.
    Rodriguez CH; Traglia G; Bastias N; Pandolfo C; Bruni G; Nastro M; Barrios R; Bavastro EM; Rey MC; Marques IA; Heger F; Vay C; Fernandez JS; Ramirez MS; Famiglietti A
    Int J Antimicrob Agents; 2019 Nov; 54(5):587-591. PubMed ID: 31400469
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Investigation of colistin sensitivity via three different methods in Acinetobacter baumannii isolates with multiple antibiotic resistance.
    Sinirtaş M; Akalin H; Gedikoğlu S
    Int J Infect Dis; 2009 Sep; 13(5):e217-20. PubMed ID: 19230734
    [TBL] [Abstract][Full Text] [Related]  

  • 79. In vitro synergistic activity of tigecycline and colistin against XDR-Acinetobacter baumannii.
    Dizbay M; Tozlu DK; Cirak MY; Isik Y; Ozdemir K; Arman D
    J Antibiot (Tokyo); 2010 Feb; 63(2):51-3. PubMed ID: 19942947
    [TBL] [Abstract][Full Text] [Related]  

  • 80. In Vitro Activities of Novel Antimicrobial Combinations against Extensively Drug-Resistant Acinetobacter baumannii.
    Córdoba J; Coronado-Álvarez NM; Parra D; Parra-Ruiz J
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7316-9. PubMed ID: 26369956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.